Table of Contents Author Guidelines Submit a Manuscript
Advances in Bioinformatics
Volume 2019, Article ID 6815105, 16 pages
https://doi.org/10.1155/2019/6815105
Research Article

Peptide-Protein Interaction Studies of Antimicrobial Peptides Targeting Middle East Respiratory Syndrome Coronavirus Spike Protein: An In Silico Approach

1Department of Biostatistics and Bioinformatics, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
2Infection Prevention and Control Department at the Ministry of National Guard, Department of Infectious Diseases, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

Correspondence should be addressed to Musa Gabere; moc.liamg@erebagm

Received 6 January 2019; Accepted 8 May 2019; Published 1 July 2019

Academic Editor: Nurit Haspel

Copyright © 2019 Sabeena Mustafa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Milne-Price, K. L. Miazgowicz, and V. J. Munster, “The emergence of the Middle East Respiratory Syndrome coronavirus,” Pathogens and Disease, vol. 71, no. 2, pp. 121–136, 2014. View at Publisher · View at Google Scholar
  2. H. A. Mohd, J. A. Al-Tawfiq, and Z. A. Memish, “Middle east respiratory syndrome coronavirus (MERS-CoV) origin and animal reservoir Susanna Lau,” Virology Journal, vol. 13, no. 1, article 87, 2016. View at Google Scholar · View at Scopus
  3. L. I. Melnik, R. F. Garry, and C. A. Morris, “Peptide inhibition of human cytomegalovirus infection,” Virology Journal, vol. 8, article 76, 2011. View at Publisher · View at Google Scholar
  4. “Safety study of flufirvitide-3 nasal spray in healthy subjects,” https://clinicaltrials.gov/ct2/show/NCT01313962?term=Flufirvitide.
  5. J. W. Koehler, J. M. Smith, D. R. Ripoll et al., “A fusion-inhibiting peptide against rift valley fever virus inhibits multiple, diverse viruses,” PLOS Neglected Tropical Diseases, vol. 7, no. 9, pp. 1–11, 2013. View at Google Scholar · View at Scopus
  6. Y. M. Hrobowski, R. F. Garry, and S. F. Michael, “Peptide inhibitors of dengue virus and West Nile virus infectivity,” Virology Journal, vol. 2, no. 1, article 49, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Sainz, E. C. Mossel, W. R. Gallaher et al., “Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein,” Virus Research, vol. 120, no. 1-2, pp. 146–155, 2006. View at Publisher · View at Google Scholar
  8. H. Badani, R. F. Garry, and W. C. Wimley, “Peptide entry inhibitors of enveloped viruses: The importance of interfacial hydrophobicity,” Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1838, no. 9, pp. 2180–2197, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. T.-J. Chia, Y.-C. Wu, J.-Y. Chen, and S.-C. Chi, “Antimicrobial peptides (AMP) with antiviral activity against fish nodavirus,” Fish and Shellfish Immunology, vol. 28, no. 3, pp. 434–439, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Lu, Q. Liu, Y. Zhu et al., “Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor,” Nature Communications, vol. 5, article 3067, 2014. View at Publisher · View at Google Scholar
  11. R. Channappanavar, L. Lu, S. Xia et al., “Protective effect of intranasal regimens containing peptidic middle east respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection,” The Journal of Infectious Diseases, vol. 212, no. 12, pp. 1894–1903, 2015. View at Publisher · View at Google Scholar
  12. J. Gao, G. Lu, J. Qi et al., “Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the s protein of middle east respiratory syndrome coronavirus,” Journal of Virology, vol. 87, no. 24, pp. 13134–13140, 2013. View at Publisher · View at Google Scholar
  13. H. Zhao, J. Zhou, K. Zhang et al., “A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses,” Scientific Reports, vol. 6, article 22008, 2016. View at Google Scholar · View at Scopus
  14. L. Du, Y. Yang, Y. Zhou et al., “MERS-CoV spike protein: a key target for antivirals,” Expert Opinion on Therapeutic Targets, vol. 21, no. 2, pp. 131–143, 2017. View at Publisher · View at Google Scholar
  15. G. Wang, X. Li, and Z. Wang, “APD3: the antimicrobial peptide database as a tool for research and education,” Nucleic Acids Research, vol. 44, no. D1, pp. D1087–D1093, 2016. View at Publisher · View at Google Scholar
  16. M. Ciemny, M. Kurcinski, K. Kamel et al., “Protein–peptide docking: opportunities and challenges,” Drug Discovery Therapy, vol. 23, no. 8, pp. 1530–1537, 2018. View at Publisher · View at Google Scholar
  17. A. V. Hoojghan, Application of graphical models in protein-protein interactions and dynamics [Ph.D. thesis], University of Massachusetts Boston.
  18. F. Zhao, H. Zeng, X. Li et al., “Complexcontact: a web server for inter-protein contact prediction using deep learning,” Nucleic Acids Research, vol. 46, no. W1, pp. W432–W437, 2018. View at Google Scholar
  19. A. Valencia, I. Ezkurdia, L. Bartoli, M. L. Tress, P. Fariselli, and R. Casadio, “Progress and challenges in predicting proteinprotein interaction sites,” Briefings in Bioinformatics, vol. 10, no. 3, pp. 233–246, 2009. View at Google Scholar
  20. H. M. Berman, J. Westbrook, Z. Feng et al., “The protein data bank,” Nucleic Acids Research, vol. 28, no. 1, pp. 235–242, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Wang, “Natural antimicrobial peptides as promising anti-hiv candidates,” Current Topics in Peptide and Protein Research, vol. 13, pp. 93–110, 2012. View at Google Scholar
  22. A. Roy, A. Kucukural, and Y. Zhang, “I-TASSER: a unified platform for automated protein structure and function prediction,” Nature Protocols, vol. 5, no. 4, pp. 725–738, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. C. Lovell, I. W. Davis, W. B. Arendall et al., “Structure validation by cα geometry: ϕ, ψ and cβ deviation,” Proteins: Structure, Function, and Bioinformatics, vol. 50, no. 3, pp. 437–450, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Chuang, D. Kozakov, R. Brenke, S. R. Comeau, and S. Vajda, “DARS (decoys as the reference state) potentials for protein-protein docking,” Biophysical Journal, vol. 95, no. 9, pp. 4217–4227, 2008. View at Publisher · View at Google Scholar
  25. D. Kozakov, R. Brenke, S. R. Comeau, and S. Vajda, “PIPER: an FFT-based protein docking program with pairwise potentials,” Proteins: Structure, Function, and Genetics, vol. 65, no. 2, pp. 392–406, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Kozakov, D. R. Hall, B. Xia et al., “The ClusPro web server for protein–protein docking,” Nature Protocols, vol. 12, no. 2, pp. 255–278, 2017. View at Publisher · View at Google Scholar
  27. K. G. Tina, R. Bhadra, and N. Srinivasan, “PIC: protein interactions calculator,” Nucleic Acids Research, vol. 35, no. 2, pp. W473–W476, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. O. Adedeji, K. Singh, A. Kassim et al., “Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and middle east respiratory syndrome coronaviruses,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 8, pp. 4894–4898, 2014. View at Publisher · View at Google Scholar
  29. E. Teissier, F. Penin, and E.-I. Pécheur, “Targeting cell entry of enveloped viruses as an antiviral strategy,” Molecules, vol. 16, no. 1, pp. 221–250, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. G. N. Ramachandran, C. Ramakrishnan, and V. Sasisekharan, “Stereochemistry of polypeptide chain configurations,” Journal of Molecular Biology, vol. 7, pp. 95–99, 1963. View at Publisher · View at Google Scholar · View at Scopus
  31. H. A. Rothan, Z. Mohamed, A. M. Suhaeb, N. A. Rahman, and R. Yusof, “Antiviral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus: high yield production of the biologically active recombinant plectasin peptide,” OMICS: A Journal of Integrative Biology, vol. 17, no. 11, pp. 560–567, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Haspel and F. Jagodzinski, Methods for Detecting Critical Residues in Proteins, Springer, New York, NY, USA, 2017.
  33. P. B. Eisenhauer, S. S. L. Harwig, D. Szklarek, T. Ganz, M. E. Selsted, and R. I. Lehrer, “Purification and antimicrobial properties of three defensins from rat neutrophils,” Infection and Immunity, vol. 57, no. 7, pp. 2021–2027, 1989. View at Google Scholar · View at Scopus
  34. A. S. Dugan, M. S. Maginnis, J. A. Jordan et al., “Human α-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells,” The Journal of Biological Chemistry, vol. 283, no. 45, pp. 31125–31132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Milona, C. L. Townes, R. M. Bevan, and J. Hall, “The chicken host peptides, gallinacins 4, 7, and 9 have antimicrobial activity against Salmonella serovars,” Biochemical and Biophysical Research Communications, vol. 356, no. 1, pp. 169–174, 2007. View at Publisher · View at Google Scholar
  36. A. Gould, Y. Ji, T. L. Aboye, and J. A. Camarero, “Cyclotides, a novel ultrastable polypeptide scaffold for drug discovery,” Current Pharmaceutical Design, vol. 17, no. 38, pp. 4294–4307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Shi, X. Hou, L. Wang et al., “Two novel dermaseptin-like antimicrobial peptides with anticancer activities from the skin secretion of Pachymedusa dacnicolor,” Toxins, vol. 8, no. 5, 2016. View at Google Scholar · View at Scopus
  38. N. Iijima, N. Tanimoto, Y. Emoto et al., “Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major,” European Journal of Biochemistry, vol. 270, no. 4, pp. 675–686, 2003. View at Publisher · View at Google Scholar
  39. S. Mustafa, H. Balkhy, and M. N. Gabere, “Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): a review,” Journal of Infection and Public Health, vol. 11, no. 1, pp. 9–17, 2018. View at Publisher · View at Google Scholar